Additionally, PNX’s impact on insulin sensitivity and glucose metabolism positions it as a candidate for addressing obesity-related metabolic disorders, such as diabetes, by improving glucose utilization and enhancing insulin sensitivity [118]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.